Cortical fibrinolytic activity in normal and diseased human kidneys.
D019867:Anti-Glomerular Basement Membrane Disease / Q000503:physiopathology; D001706:Biopsy; D003928:Diabetic Nephropathies / Q000503:physiopathology; D005342:Fibrinolysis; D005921:Glomerulonephritis / Q000503:physiopathology; D006084:Graft Rejection; D006417:Hematuria / Q000503:physiopathology; D006463:Hemolytic-Uremic Syndrome / Q000188:drug therapy / Q000503:physiopathology; D006801:Humans; D007668:Kidney / Q000473:pathology / Q000502:physiology*; D007674:Kidney Diseases / Q000503:physiopathology*; D007678:Kidney Glomerulus / Q000473:pathology; D016030:Kidney Transplantation; D008180:Lupus Erythematosus, Systemic / Q000503:physiopathology; D008856:Microscopy, Fluorescence; D009393:Nephritis / Q000235:genetics / Q000503:physiopathology; D009401:Nephrosis / Q000151:congenital / Q000503:physiopathology; D009404:Nephrotic Syndrome / Q000503:physiopathology; D011693:Purpura / Q000503:physiopathology; D013300:Streptokinase / Q000627:therapeutic use
D013300:Streptokinase